title: Phospholamban S-nitrosylation modulates Starling response in fish heart.
abstract: The Frank-Starling mechanism is a fundamental property of the vertebrate heart, which allows the myocardium to respond to increased filling pressure with a more vigorous contraction of its lengthened fibres. In mammals, myocardial stretch increases cardiac nitric oxide (NO) release from both vascular endothelium and cardiomyocytes. This facilitates myocardial relaxation and ventricular diastolic distensibility, thus influencing the Frank-Starling mechanism. In the in vitro working heart of the eel Anguilla anguilla, we previously showed that an endogenous NO release affects the Frank-Starling response making the heart more sensitive to preload. Using the same bioassay, we now demonstrate that this effect is confirmed in the presence of the exogenous NO donor S-nitroso-N-acetyl penicillamine, is independent from endocardial endothelium and guanylate cyclase/cGMP/protein kinase G and cAMP/protein kinase A pathways, involves a PI(3)kinase-mediated activation of endothelial NO synthase and a modulation of the SR-CA(2+)ATPase (SERCA2a) pumps. Furthermore, we show that NO influences cardiac response to preload through S-nitrosylation of phospholamban and consequent activation of SERCA2a. This suggests that in the fish heart NO modulates the Frank-Starling response through a beat-to-beat regulation of calcium reuptake and thus of myocardial relaxation. We propose that this mechanism represents an important evolutionary step for the stretch-induced intrinsic regulation of the vertebrate heart, providing, at the same time, a stimulus for mammalian-oriented studies.
authors.affiliation: Department of Cell Biology, University of Calabria, , 87030 Arcavacata di Rende, Cosenza, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Garofalo
authors.forename: M L
authors.initials: ML
authors.lastname: Parisella
authors.forename: D
authors.initials: D
authors.lastname: Amelio
authors.forename: B
authors.initials: B
authors.lastname: Tota
authors.forename: S
authors.initials: S
authors.lastname: Imbrogno
mesh_terms: D000818:Animals; D002135:Calcium-Binding Proteins / Q000378:metabolism / Q000494:pharmacology*; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism; D004524:Eels / Q000502:physiology*; D004699:Endocardium / Q000502:physiology; D004727:Endothelium / Q000378:metabolism; D005786:Gene Expression Regulation / Q000502:physiology; D006321:Heart / Q000502:physiology*; D009569:Nitric Oxide / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D026423:S-Nitroso-N-Acetylpenicillamine / Q000494:pharmacology; D015398:Signal Transduction; D017725:Ventricular Pressure / Q000502:physiology; D000099211:Phospholamban
chemical_list: D002135:Calcium-Binding Proteins; D000242:Cyclic AMP; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D026423:S-Nitroso-N-Acetylpenicillamine; D000099211:Phospholamban